IVERIC bio, Inc. - Common Stock (NQ:ISEE)

N/A UNCHANGED

Last Price Updated: 4:00 PM EDT, Jul 10, 2023 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about IVERIC bio, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

Iveric Bio Shares Shoot Higher Following Positive Top-line Data From Late-Stage Geographic Atrophy Study ↗

September 06, 2022

Iveric Bio (NASDAQ: ISEE) announced positive topline results from the second Phase 3 clinical trial of Zimura (avacincaptad pegol) for the treatment of geographic atrophy (GA).

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

September 06, 2022

Via Benzinga

IVERIC bio Stock Soars After Encouraging Geographic Atrophy Trial Data ↗

September 06, 2022

IVERIC bio Inc (NASDAQ: ISEE) announced positive data from the second Phase 3 trial of Zimura (avacincaptad pegol) for geographic atrophy (GA).

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

September 06, 2022

Good morning, trader! It's time to start off the day with a breakdown of the biggest pre-market stock movers for Tuesday morning!

Via InvestorPlace

What 5 Analyst Ratings Have To Say About IVERIC bio ↗

August 02, 2022

Within the last quarter, IVERIC bio (NASDAQ:ISEE) has observed the following analyst ratings:

Via Benzinga

IVERIC bio Shares Jump On Debt Financing To Fund Zimura Launch ↗

July 26, 2022

Via Benzinga

Recap: IVERIC bio Q2 Earnings ↗

July 26, 2022

IVERIC bio (NASDAQ:ISEE) reported its Q2 earnings results on Tuesday, July 26, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

Iveric Bio Announces Positive Topline Data from Zimura® GATHER2 Phase 3 Clinical Trial in Geographic Atrophy

September 06, 2022

From IVERIC bio, Inc.

Via Business Wire

Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

September 02, 2022

From IVERIC bio, Inc.

Via Business Wire

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

August 25, 2022

Via Benzinga

Earnings Scheduled For July 26, 2022 ↗

July 26, 2022

Companies Reporting Before The Bell • General Motors (NYSE:GM) is likely to report quarterly earnings at $1.30 per share on revenue of $34.59 billion.

Via Benzinga

Short Volatility Alert: IVERIC bio, Inc. ↗

July 21, 2022

On Wednesday, shares of IVERIC bio, Inc. (NASDAQ: ISEE) experienced volatile short activity. After the activity, the stock price went up +1.70% to $11.95. The overall sentiment for ISEE has been...

Via Benzinga

Expert Ratings for IVERIC bio ↗

July 07, 2022

IVERIC bio (NASDAQ:ISEE) has observed the following analyst ratings within the last quarter:

Via Benzinga

Why Several Chinese Stocks Traded Higher; Here Are 58 Biggest Movers From Yesterday ↗

August 26, 2022

Gainers Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) surged 95.3% to close at $0.2580 on Thursday after Ladenburg Thalmann initiated coverage on the stock with a Buy rating and announced a price target...

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

August 17, 2022

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...

Via Benzinga

Iveric Bio to Participate in the H.C. Wainwright 2nd Annual Ophthalmology Virtual Conference

August 10, 2022

From IVERIC bio, Inc.

Via Business Wire

7 Cheap Biotech Stocks to Buy Now ↗

August 03, 2022

These cheap biotech stocks to buy offer investors a way to get ready for the inevitable comeback in the biopharmaceutical sector.

Via InvestorPlace

Iveric Bio to Present at the Wedbush PacGrow Healthcare Conference 2022

August 03, 2022

From IVERIC bio, Inc.

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For August 2, 2022 ↗

August 02, 2022

Upgrades

Via Benzinga

Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

August 02, 2022

From IVERIC bio, Inc.

Via Business Wire

3 Biotech Stock Picks From This Wedbush Analyst ↗

July 27, 2022

While the S&P 500 index peaked in January and has had a rough year, the biotech sector peaked last August. For the time being, both have found a short-term and possible long-term bottom in June.

Via Benzinga

Daily Biotech Pulse: EU Approval For AbbVie's Ulcerative Colitis Treatment, Angion Biomedica Evaluates Alternatives, Clinical Hold For Immuron's Bacterial Infection Candidate ↗

July 26, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Alibaba, General Electric And Some Other Big Stocks Moving Higher In Today's Pre-Market Session ↗

July 26, 2022

Redbox Entertainment Inc. (NASDAQ: RDBX) rose 11.5% to $6.19 in pre-market trading after jumping 82% on Monday.

Via Benzinga

Iveric Bio Reports Second Quarter 2022 Operational Highlights and Financial Results

July 26, 2022

From IVERIC bio, Inc.

Via Business Wire

Iveric Bio Announces Agreement for Up to $250 Million in Non-Dilutive Debt Financing with Hercules Capital and Silicon Valley Bank

July 26, 2022

From IVERIC bio, Inc.

Via Business Wire

Earnings Preview: IVERIC bio ↗

July 25, 2022

IVERIC bio (NASDAQ:ISEE) is set to give its latest quarterly earnings report on Tuesday, 2022-07-26. Here's what investors need to know before the announcement. Analysts estimate that IVERIC bio will...

Via Benzinga

Iveric Bio to Report Second Quarter 2022 Financial Results and Host Conference Call on Tuesday, July 26, 2022

July 21, 2022

From IVERIC bio, Inc.

Via Business Wire

Iveric Bio Announces Post-Hoc Analysis from GATHER1 Clinical Trial of Zimura® at American Society of Retina Specialists Meeting

July 16, 2022

From IVERIC bio, Inc.

Via Business Wire

The Daily Biotech Pulse: AstraZeneca Goes Shopping, TYME Technologies & Syros Pharma Merger, FDA Clears Vertex Pharma's Stem Cell-Based Diabetes Therapy Study ↗

July 05, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Iveric Bio and DelSiTech Enter Exclusive Agreement for Development of Sustained Release Zimura®

July 05, 2022

From IVERIC bio, Inc.

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.